48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort

BACKGROUND: The main international guidelines indicate DTG/3TC therapy as one of the preferred regimens for people living with HIV (PLWH), due to its observed efficacy in randomized clinical trials. However, information in real-life cohorts is relatively scarce for first-line use. METHODS: A retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabello-Ubeda, Alfonso, de Quirós, Juan Carlos López Bernardo, Martín Carbonero, Luz, Sanz, Jesús, Vergas, Jorge, Mena, Álvaro, Torralba, Miguel, Hernández Segurado, Marta, Pinto, Adriana, Tejerina, Francisco, Palmier, Esmeralda, Gutiérrez, Ángela, Vázquez, Pilar, Pulido, Federico, Górgolas, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678299/
https://www.ncbi.nlm.nih.gov/pubmed/36409695
http://dx.doi.org/10.1371/journal.pone.0277606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678299/
https://www.ncbi.nlm.nih.gov/pubmed/36409695
http://dx.doi.org/10.1371/journal.pone.0277606

Ejemplares similares